Identification of CYP2C9 and VKORC1 polymorphisms in Iranian patients who are under warfarin therapy

Background: Although catalytic properties of different genetic polymorphisms of VKORC1 and CYP2C9 products have been identified, there is limited study available regarding warfarin dose requirement in Iranian patient population. This study investigates the impact of these polymorphisms on 115 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Poopak, Behzad, Rabieipoor, Saghar, Safari, Nazila, Naraghi, Emadedin, Sheikhsofla, Fatemeh, Khosravipoor, Gelareh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748690/
https://www.ncbi.nlm.nih.gov/pubmed/26865929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748690/
https://www.ncbi.nlm.nih.gov/pubmed/26865929

Ejemplares similares